SECSONAR

$VRDN

Viridian Therapeutics, Inc.

NASDAQ

Director, 10% Owner bought $20.0M

44% below 52-week high

Revenue growing

Insider cost basis

Insiders bought — stock holding above

+11.4%vs buy

Insider buy $17.00Now $18.93

Find before everyone else

SEC filings, insider trades & earnings for VRDN — in one place.